Cargando…
Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease
Circulating fatty acid composition is assumed to play an important role in metabolic dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to investigate the association between the overall balance of serum fatty acid composition and MAFLD prevalence. This cross-sectional...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960614/ https://www.ncbi.nlm.nih.gov/pubmed/36839168 http://dx.doi.org/10.3390/nu15040809 |
_version_ | 1784895554896003072 |
---|---|
author | Nagase, Yuka Satoh, Takao Shigetome, Keiichi Tokumaru, Naoto Matsumoto, Erika Yamada, Kazunori D. Imafuku, Tadashi Watanabe, Hiroshi Maruyama, Toru Ogata, Yasuhiro Yoshida, Minoru Saruwatari, Junji Oniki, Kentaro |
author_facet | Nagase, Yuka Satoh, Takao Shigetome, Keiichi Tokumaru, Naoto Matsumoto, Erika Yamada, Kazunori D. Imafuku, Tadashi Watanabe, Hiroshi Maruyama, Toru Ogata, Yasuhiro Yoshida, Minoru Saruwatari, Junji Oniki, Kentaro |
author_sort | Nagase, Yuka |
collection | PubMed |
description | Circulating fatty acid composition is assumed to play an important role in metabolic dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to investigate the association between the overall balance of serum fatty acid composition and MAFLD prevalence. This cross-sectional study involved 400 Japanese individuals recruited from a health-screening program. We measured fatty acids in serum lipids using gas chromatography–mass spectrometry. The serum fatty acid composition balance was evaluated using fuzzy c-means clustering, which assigns individual data points to multiple clusters and calculates the percentage of data points belonging to multiple clusters, and serum fatty acid mass%. The participants were classified into four characteristic subclasses (i.e., Clusters 1, 2, 3, and 4), and the specific serum fatty acid composition balance (i.e., Cluster 4) was associated with a higher MAFLD prevalence. We suggest that the fuzzy c-means method can be used to determine the circulating fatty acid composition balance and highlight the importance of focusing on this balance when examining the relationship between MAFLD and serum fatty acids. |
format | Online Article Text |
id | pubmed-9960614 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-99606142023-02-26 Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease Nagase, Yuka Satoh, Takao Shigetome, Keiichi Tokumaru, Naoto Matsumoto, Erika Yamada, Kazunori D. Imafuku, Tadashi Watanabe, Hiroshi Maruyama, Toru Ogata, Yasuhiro Yoshida, Minoru Saruwatari, Junji Oniki, Kentaro Nutrients Article Circulating fatty acid composition is assumed to play an important role in metabolic dysfunction-associated fatty liver disease (MAFLD) pathogenesis. This study aimed to investigate the association between the overall balance of serum fatty acid composition and MAFLD prevalence. This cross-sectional study involved 400 Japanese individuals recruited from a health-screening program. We measured fatty acids in serum lipids using gas chromatography–mass spectrometry. The serum fatty acid composition balance was evaluated using fuzzy c-means clustering, which assigns individual data points to multiple clusters and calculates the percentage of data points belonging to multiple clusters, and serum fatty acid mass%. The participants were classified into four characteristic subclasses (i.e., Clusters 1, 2, 3, and 4), and the specific serum fatty acid composition balance (i.e., Cluster 4) was associated with a higher MAFLD prevalence. We suggest that the fuzzy c-means method can be used to determine the circulating fatty acid composition balance and highlight the importance of focusing on this balance when examining the relationship between MAFLD and serum fatty acids. MDPI 2023-02-04 /pmc/articles/PMC9960614/ /pubmed/36839168 http://dx.doi.org/10.3390/nu15040809 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nagase, Yuka Satoh, Takao Shigetome, Keiichi Tokumaru, Naoto Matsumoto, Erika Yamada, Kazunori D. Imafuku, Tadashi Watanabe, Hiroshi Maruyama, Toru Ogata, Yasuhiro Yoshida, Minoru Saruwatari, Junji Oniki, Kentaro Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title | Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title_full | Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title_fullStr | Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title_full_unstemmed | Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title_short | Serum Fatty Acid Composition Balance by Fuzzy C-Means Method in Individuals with or without Metabolic Dysfunction-Associated Fatty Liver Disease |
title_sort | serum fatty acid composition balance by fuzzy c-means method in individuals with or without metabolic dysfunction-associated fatty liver disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9960614/ https://www.ncbi.nlm.nih.gov/pubmed/36839168 http://dx.doi.org/10.3390/nu15040809 |
work_keys_str_mv | AT nagaseyuka serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT satohtakao serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT shigetomekeiichi serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT tokumarunaoto serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT matsumotoerika serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT yamadakazunorid serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT imafukutadashi serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT watanabehiroshi serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT maruyamatoru serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT ogatayasuhiro serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT yoshidaminoru serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT saruwatarijunji serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease AT onikikentaro serumfattyacidcompositionbalancebyfuzzycmeansmethodinindividualswithorwithoutmetabolicdysfunctionassociatedfattyliverdisease |